| Financial Year |
March 31 2023 |
| Monetary Funds |
858,223,602.54 |
| Held-for-trading Financial Assets |
36,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
484,886,672.61 |
| Advances to Suppliers |
54,532,152.36 |
| Other Receivables |
20,063,703.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
699,897,080.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,962,957.80 |
| Total Current Assets |
2,228,093,885.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
339,356,689.22 |
| Investment Properties |
94,045,323.21 |
| Fixed Assetes |
1,488,960,476.83 |
| Under-construction Projects |
1,200,635,283.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
477,943,791.73 |
| R&D expenses |
646,032,106.62 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,882,350.58 |
| Deferred Income Tax Assets |
46,679,731.89 |
| Other Non-Current Assets |
417,250,698.58 |
| Sub-Total of Non-Current Assets |
4,769,986,451.69 |
| Total Assets |
6,998,080,337.53 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,234,655.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
957,258.77 |
| Taxes Payable |
38,037,610.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,787,961.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
152,353.96 |
| Sub-Total of Current Liabilities |
164,335,063.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,506,858.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,676,519.97 |
| Total Liabilities |
200,011,583.14 |
| Paid-In Capital(Or Share Stock) |
1,993,678,653.00 |
| Capital Surplus |
640,032,644.64 |
| Surplus Reserve |
1,027,149,340.36 |
| LESS:Treasury Stock |
150,365,829.95 |
| Undistributed Profits |
3,275,951,910.67 |
| Minority Stockholder's Interest |
5,235,785.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,792,832,969.04 |
| Owner's Equity（Stockholder's Equity） |
6,798,068,754.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,998,080,337.53 |
